Sugawara Tomoko | Department Of Cardiovascular Medicine Hokkaido University School Of Medicine

スポンサーリンク

概要

• Sugawara Tomokoの詳細を見る
• 同名の論文著者
• Department Of Cardiovascular Medicine Hokkaido University School Of Medicineの論文著者

Department Of Cardiovascular Medicine Hokkaido University School Of Medicine | 論文

• 1 Pharmacogenomics of β-blocker Therapy in Chronic Heart Failure(New Approaches to Heart Failure-from Pharmacogenomics to Drug Development, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• Which is most Beneficial for Preserving Cardiac Function and Coronary Microvasculaturein DCM, ACE-I, ARB or Two in Combination? (Cardiac Hypertrophy/Cardiomyopathy 2 (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• Eplerenone Prevents Cardiac Fibrosis through the Inhibition of OPN Expression (Cardiac Hypertrophy, Basic (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• Osteopontin is Essential for Angiotensin II-Induced Cardiac Fibrosis(Heart Failure, Basic 2 (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• -1075-A PHTHALAZINE DERIVATIVE, MCI-116, REDUCES INFARCT SIZE IN ASSOCIATION WITH SUPPRESSION OF NEUTROPHIL FUNCTION IN A CANINE CORONARY REPERFUSION MODEL : THE 54th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY

もっと見る

スポンサーリンク